Most recently, with the support of up to $10.4 million from BARDA, the Company developed the OraQuick Ebola Rapid Antigen Test which received … Full Article http://j.gs/5sTq
Click here to read full articleMost recently, with the support of up to $10.4 million from BARDA, the Company developed the OraQuick Ebola Rapid Antigen Test which received … Full Article http://j.gs/5sTq
Click here to read full article
No comments:
Post a Comment